Acute heart failure and biomarkers: time also matters, don't relax
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.880
Abstract: Over the last 20 years, biomarkers have represented one of the most attractive topics in heart failure (HF) studies. Before 1998, the search “heart failure and biomarker”1 provided fewer than one hundred scientific papers per… read more here.
Keywords: failure biomarkers; heart; time; heart failure ... See more keywords
Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives
Sign Up to like & getrecommendations! Published in 2017 at "Current Heart Failure Reports"
DOI: 10.1007/s11897-017-0321-4
Abstract: IntroductionHeart failure (HF) is a complex clinical syndrome with diverse risk factors and etiologies, differing underlying pathophysiology, and large phenotypic heterogeneity.Recent FindingsAdvances in imaging techniques coupled with clinical trials that targeted only in those with… read more here.
Keywords: failure biomarkers; clinical phenotyping; heart failure; phenotyping heart ... See more keywords
Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
Sign Up to like & getrecommendations! Published in 2018 at "Theranostics"
DOI: 10.7150/thno.26055
Abstract: Plasma heart failure (HF) biomarkers, like natriuretic peptides, are important in diagnosis, prognosis and HF treatment. Several novel HF biomarkers have been identified, including Gal-3, GDF-15 and TIMP-1, but their clinical potential remains vague. Here… read more here.
Keywords: failure biomarkers; plasma; heart failure; expression ... See more keywords